Patient Satisfaction and Pain with Ambulatory Bulkamid Injection
Jennifer Hamner
Primary Investigator
Brief description of study
What is the purpose of this study?
This research will employ a prospective study design to investigate patient satisfaction and pain with ambulatory Bulkamid injection. Patients who are scheduled for ambulatory Bulkamid injections will be eligible for the study.
Detailed description of study
What will happen during the study?
This study will compare anticipated and experienced pain with ambulatory Bulkamid injection to assess patient satisfaction with ambulatory Bulkamid injection. Patients will fill out a VAS form with their anticipated pain experience for the procedure.
- Then they will undergo the procedure as planned.
- Within 1 hour after completion of the procedure, they will complete an identical VAS documenting their experienced pain during the procedure.
- On post-procedure day 1, they will receive a phone call to check on them. They will be asked if they would undergo ambulatory procedure again if needed10
- Chart review will be performed to collect patient background information and procedural
data.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Stress urinary incontinence, SUI
-
Age: 18 years - 100 years
-
Gender: Female
Inclusion criteria:
- Women aged 18 and older who undergo cystoscopy with intraurethral Bulkamid injection within the Indiana University Health and Eskenazi Health systems.
- Must be English-speaking
- Must be neurologically intact without prior urethral trauma
Exclusion criteria:
- Have concomitant procedures performed (bladder biopsies, etc), history of spinal cord injury with loss of sensation, have
chronic narcotic use, have had previous Bulkamid injections, or are undergoing active cancer treatment.
